当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › Expert Opinion on Drug Delivery杂志
Expert Opinion on Drug Delivery
基本信息
期刊名称 Expert Opinion on Drug Delivery
EXPERT OPIN DRUG DEL
期刊ISSN 1742-5247
期刊官方网站 https://www.tandfonline.com/journals/iedd20
是否OA No
出版商 Taylor and Francis Ltd.
出版周期 Bimonthly
文章处理费 登录后查看
始发年份 2004
年文章数 103
影响因子 5.0(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 11.1 1.009 1.090
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
13/183 93%
补充信息
自引率 4%
H-index 88
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1742-5247%5BISSN%5D
投稿指南
期刊投稿网址 https://mc.manuscriptcentral.com/eodd
收稿范围
Expert Opinion on Drug Delivery (1742-5247; 1744-7593) is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles in drug delivery.

Articles cover all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The journal welcomes:

    Reviews covering delivery technologies, vehicles and devices; nanotechnology; novel formulations; the delivery of specific drug and therapeutic classes; gene/vaccine delivery strategies; modes of entry into the body and applications in certain diseases and disorders
    Technology evaluations reviewing a particular drug delivery technology
    Original research contributions are welcomed in the form of:
    - Delivery technologies, vehicles, formulations and devices;
    - The delivery of specific drugs and therapeutic classes;
    - Modes of entry into the body and applications in certain diseases and disorders.

    Editorials commenting on the various drug delivery strategies which have been, and are being, explored
    Guidelines on the application of specific drug delivery systems, or in specific disease indications.


The audience for the journal consists of scientists and managers in the healthcare and pharmaceutical industry, academic pharmaceutical scientists and others closely involved in the delivery of drugs and other therapeutic agents.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees. Publish in 3 weeks from submission with Accelerated Publication.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Opinion on Drug Delivery, part of the Expert Collection brand.
收录体裁
投稿指南 https://www.tandfonline.com/action/authorSubmission?show=instructions&journalCode=iedd20
投稿模板
参考文献格式
编辑信息

EDITOR IN CHIEF

Uday Kompella: University of Colorado, CO, USA

 

EDITORIAL ADVISORY BOARD

Mansoor Amiji: Northeastern University, Boston, MA, USA

Nicholas Bodor: University of Florida, Gainesville, FL, USA

Pieter R Cullis: University of British Columbia, Vancouver, Canada

Elias Fattal: University of Paris - South, Paris, France

Warren Finlay: University of Alberta, Alberta, Edmonton, Canada

Hideyoshi Harashima: Hokkaido University, Hokkaido, Japan

Yogeshvar Kalia: University of Geneva, Geneva, Switzerland

Robert Langer: Massachusetts Institute of Technology, Cambridge, USA

Ram I Mahato: University of Nebraska, USA

Ashim Mitra: University of Missouri, Kansas City, MO, USA

Pankaj Modi: Generex Biotechnology Corporation, Canada

Ravin Narain: University of Alberta, Canada

Seshadri Neervannan: Allergan Inc, USA

Steve Newman: Scientific Consultant, Nottingham, England, UK

Abdel Omri: Laurentian University, Sudbury, Ontario, Canada

Nicholas Peppas: University of Texas, Austin, TX, USA

Michael A Repka: University of Mississippi, MS, USA

Christopher Rhodes: Amylin Pharmaceuticals Inc., San Diego, CA, USA

Abraham Rubinstein: Hebrew University of Jerusalem, Jerusalem, Israel

Bruno Sarmento: University of Porto, Portugal

Alan Smith: Altea therapeutics, Atlanta, GA, USA

Thomas Tice: Evonik Degussa Corporation, Birmingham, AL, USA

Vladimir Torchilin: Northeastern University, Boston, MA

Neeraj Vij: John Hopkins University, Baltimore, USA


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug